Filling and voiding symptoms in the American Urological Association symptom index: The value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia

被引:37
作者
Barry, MJ [1 ]
Williford, WO
Fowler, FJ
Jones, KM
Lepor, H
机构
[1] Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA
[2] Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA
[3] Vet Affairs Med Ctr, Cooperat Studies Program, Coordinating Ctr, Perry Point, MD USA
[4] NYU Med Ctr, New York, NY 10016 USA
[5] Vet Affairs Med Ctr, New York, NY USA
关键词
prostate; urination disorders; prostatic hyperplasia; urinary tract; health status indicators;
D O I
10.1016/S0022-5347(05)67028-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We used data from a large Veterans Affairs trial of medical therapy for men with benign prostatic hyperplasia to evaluate the value of calculating separate filling and voiding subscores of the American Urological Association (AUA) symptom index. Materials and Methods: We performed factor analysis to assess the psychometric validity of separating the 7 items of the AUA symptom index into filling and voiding subsets. To assess the clinical usefulness of calculating these subscores we correlated them against baseline measurements of symptom interference as well as urodynamic and anatomical measures of disease severity, and used them for predicting the response to medical therapy. Results: Factor analysis confirmed the psychometric validity of separating the AUA symptom index into a 3-item filling and a 4-item voiding subscale. However, calculating filling and voiding subscores did not result in differential correlations with measures of disease interference or severity. It also did not enable us to predict a better symptomatic or uroflowmetry response to medical therapy. Conclusions: Calculating separate filling and voiding subscores of the AUA symptom index is psychometrically valid but not clinically useful.
引用
收藏
页码:1559 / 1564
页数:6
相关论文
共 15 条
  • [1] NEW WORDS FOR OLD - LOWER URINARY-TRACT SYMPTOMS FOR PROSTATISM
    ABRAMS, P
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6934) : 929 - 930
  • [2] BARRY MJ, 1995, MED CARE, V33, pAS145
  • [3] THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    FOWLER, FJ
    OLEARY, MP
    BRUSKEWITZ, RC
    HOLTGREWE, HL
    MEBUST, WK
    COCKETT, ATK
    BLAIVAS, JG
    WEIN, AJ
    [J]. JOURNAL OF UROLOGY, 1992, 148 (05) : 1549 - 1557
  • [4] Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
    Boyle, P
    Gould, AL
    Roehrborn, CG
    [J]. UROLOGY, 1996, 48 (03) : 398 - 405
  • [5] Deyo RA, 1991, CONTROLLED CLIN TRIA, V12, P142
  • [6] elDin KE, 1996, UROLOGY, V48, P393
  • [7] The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response
    Lepor, H
    Williford, WO
    Barry, MJ
    Haakenson, C
    Jones, K
    [J]. JOURNAL OF UROLOGY, 1998, 160 (04) : 1358 - 1367
  • [8] The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
    Lepor, H
    Williford, WO
    Barry, MJ
    Brawer, MK
    Dixon, CM
    Gormley, G
    Haakenson, C
    Machi, M
    Narayan, P
    Padley, RJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) : 533 - 539
  • [9] The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
    McConnell, JD
    Bruskewitz, R
    Walsh, P
    Andriole, G
    Lieber, M
    Holtgrewe, HL
    Albertsen, P
    Roehrborn, CG
    Nickel, JC
    Wang, DZ
    Taylor, AM
    Waldstreicher, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (09) : 557 - 563
  • [10] MEBUST WK, 1991, INT CONS BEN PROST H, P51